Daniela Miliziano
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Data analytics for real-world data integration in TKI-treated NSCLC patients using electronic health records.
Journal: ESMO real world data and digital oncology
Published: February 06, 2026
Retreatment with First-Generation Selective RET Inhibitors in RET-Rearranged NSCLC Pretreated with Selpercatinib or Pralsetinib: Results from the RET-MAP Registry.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 23, 2025
Angiogenesis and thymic epithelial tumors: from preclinical insights to different therapeutic lines and combination strategies.
Journal: Cancer treatment reviews
Published: September 23, 2025
Real-World Outcomes of Molecular Tumor Board Treatment Recommendations.
Journal: JCO precision oncology
Published: June 11, 2025
Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR-positive/HER2-negative BC patients: results from the multicenter PALMARES-2 study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 02, 2024
Histologic Transformation of ALK-Rearranged Lung Adenocarcinomas to High-Grade LCNEC: Clinical and Molecular Description of Three Cases.
Journal: Clinical lung cancer
Published: June 13, 2024
Response to lorlatinib rechallenge in a case of ALK-rearranged metastatic NSCLC with a resistance mutation to second generation TKIs.
Journal: Tumori
Published: April 16, 2024
Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 28, 2023
STYLE (NCT03449173): A Phase 2 Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 20, 2022
Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors: a retrospective, multicenter, real-world study.
Journal: ESMO open
Published: March 23, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026